From: Engineered metal based nanoparticles and innate immunity
NPs | Cells | Effects | Ref |
---|---|---|---|
CoNPs ZnONPs CeO2NPs TiO2NPs | Mononyte/Macrophages | Necrosis (dependent on dose, size, concentration, structure | |
AgNP ZiONP | Monocyte/Macrophages | -IL-8 and IL-1β production (size-dependent) | |
-Oxidative stress | |||
-Inflammasome induction | |||
CoNPs | Human PBMCs | -Increase of TNF-α, IFN-γ | [41] |
-Inhibition of IL-2, IL-10 | |||
CuONP | Neutrophils | -Neutrophil recruitment and activation | |
-Increase of IL-6, IL-12, GM-CSF, KC, MCP-1, MIP-α, TNF-α | |||
CuONPs | Neutrophils | -Reduced bacterial killing | |
Fe2O3NPs | Lung lymph node cells | -Increased cytokine production | [47] |
ZnONPs | Monocyte/Macrophages | -Toxicity (dose-dependent) | [48] |
-Cell death (ion relese-dependent) | |||
CoNP | Human PBMC | -Autophagy | [20] |
PdNPs | Human PBMC | -Autophagy | [20] |
-Cell cycle (prolongation of G1-phase) | |||
-Increase of IL-8 | |||
Coated NPs | Monocyte-derived macrophages | -Variable cytotoxicity |